Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in Libya
Libya: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology was 0.2% in 2024. ▬ Flat
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in Libya, 2015–2024
Source: United Nations Statistics Division, SDG Global Database.
Analysis
In 2024, prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in Libya stood at 0.2%. That is the highest value across all 10 years on record.
That represents a change of unchanged over ten years.
Over the whole period, prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in Libya peaked at 0.2% in 2015 and was at its lowest, 0.2%, in 2015.
Libya ranks 99th of 247 countries on this measure, in the middle of the range.
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in Libya, year by year
| Year | Value | Change |
|---|---|---|
| 2015 | 0.2% | — |
| 2016 | 0.2% | +0.0% |
| 2017 | 0.2% | +0.0% |
| 2018 | 0.2% | +0.0% |
| 2019 | 0.2% | +0.0% |
| 2020 | 0.2% | +0.0% |
| 2021 | 0.2% | +0.0% |
| 2022 | 0.2% | +0.0% |
| 2023 | 0.2% | +0.0% |
| 2024 | 0.2% | +0.0% |
Libya compared with similar countries
- Libya's 0.2% is above the median for upper middle income countries, which is 0.2%, 1.0× the median. (55 countries reporting)
- Libya's 0.2% is above the median for Middle East, North Africa, Afghanistan & Pakistan, which is 0.1%, 2.0× the median. (21 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 0.2% | 0.2% | 0.2% | 5 |
| 2020s | 0.2% | 0.2% | 0.2% | 5 |
Countries ranked near Libya
- 99 Anguilla 0.2% compare
- 99 Antigua and Barbuda 0.2% compare
- 99 Aruba 0.2% compare
- 99 Bahamas 0.2% compare
- 99 Barbados 0.2% compare
- 99 Bonaire, Sint Eustatius and Saba 0.2% compare
- 99 British Virgin Islands 0.2% compare
- 99 Cayman Islands 0.2% compare
- 99 Curaçao 0.2% compare
- 99 Dominica 0.2% compare
- 99 Fiji 0.2% compare
- 99 Grenada 0.2% compare
- 99 Guadeloupe 0.2% compare
- 99 India 0.2% compare
- 99 Jamaica 0.2% compare
- 99 Kazakhstan 0.2% compare
- 99 Maldives 0.2% compare
- 99 Martinique 0.2% compare
- 99 Montserrat 0.2% compare
- 99 Nepal 0.2% compare
- 99 North Macedonia 0.2% compare
- 99 Pakistan 0.2% compare
- 99 Puerto Rico 0.2% compare
- 99 Saint Barthélemy 0.2% compare
- 99 Saint Kitts and Nevis 0.2% compare
- 99 Saint Lucia 0.2% compare
- 99 Saint Martin (French part) 0.2% compare
- 99 Saint Vincent and the Grenadines 0.2% compare
- 99 Sint Maarten (Dutch part) 0.2% compare
- 99 Suriname 0.2% compare
- 99 Tajikistan 0.2% compare
- 99 Turks and Caicos Islands 0.2% compare
- 99 United States Virgin Islands 0.2% compare
- 99 Venezuela (Bolivarian Republic of) 0.2% compare
- 99 Curacao 0.2% compare
More development goals data for Libya
- Red List Index 0.8885 (2025)
- Number of refugees per 100,000 population, by country of origin 234.4 (2025)
- Manufacturing value added per capita 247.6 (2025)
- Number of transboundary breeds 12 (2025)
- Number of transboundary breeds (not extinct) 12 (2025)
- Number of transboundary breeds with unknown risk status 12 (2025)
- Number of local breeds with unknown risk status 10 (2025)
- Number of local breeds (not extinct) 11 (2025)
- Number of local breeds kept in the country 11 (2025)
- Infant deaths 968 (2024)
Frequently asked questions
- What is prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in Libya?
- Prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in Libya was 0.2% in 2024, according to United Nations Statistics Division, SDG Global Database.
- What is the highest prevalence of hepatitis b surface antigen (hbsag), 2026 methodology recorded in Libya?
- The highest recorded value was 0.2% in 2015.
- What is the lowest prevalence of hepatitis b surface antigen (hbsag), 2026 methodology recorded in Libya?
- The lowest recorded value was 0.2% in 2015.
- How does Libya rank for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Libya ranks 99th out of 247 countries with data for 2024.
- Is prevalence of hepatitis b surface antigen (hbsag), 2026 methodology rising or falling in Libya?
- Over the last ten years it is unchanged. The long-run trend across the full record is flat.
- Where does this Libya data come from?
- The figures come from United Nations Statistics Division, SDG Global Database, published as part of Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 10 observations, free to reuse under UN SDG Global Database (open, attribution requested).